Ron Peters

Ability of Recombinant Factor VIIa to Reverse the Anticoagulant Effect of the Pentasaccharide Fondaparinux in Healthy Volunteers

Nick R. Bijsterveld, Arno H. Moons, S. Matthijs Boekholdt et al. · Circulation · 2002 · 322 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Randomized, Blinded Trial Comparing Fondaparinux With Unfractionated Heparin in Patients Undergoing Contemporary Percutaneous Coronary Intervention

Shamir R. Mehta, Philippe Gabríel Steg, Christopher B. Granger et al. · Circulation · 2005 · 118 citations

Medicine, Pharmacology, Pharmacotherapy +17

Recombinant factor VIIa reverses the anticoagulant effect of the long‐acting pentasaccharide idraparinux in healthy volunteers

Nick R. Bijsterveld, Roel Vink, Benien E. van Aken et al. · British Journal of Haematology · 2004 · 109 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Screening for Glucose Perturbations and Risk Factor Management in Dysglycemic Patients With Coronary Artery Disease—A Persistent Challenge in Need of Substantial Improvement: A Report From ESC EORP EUROASPIRE V

Giulia Ferrannini, Dirk De Bacquer, Guy De Backer et al. · Diabetes Care · 2020 · 79 citations · Full text

Medicine, Cardiology, Internal Medicine +15

Prediction of Restenosis After Coronary Balloon Angioplasty

Ron Peters, Wouter E.M. Kok, Carlo Di Mario et al. · Circulation · 1997 · 69 citations

Medicine, Cardiology, Clinical Sciences +17